BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1477 related articles for article (PubMed ID: 19757346)

  • 41. Adenocarcinoma of the Esophagogastric Junction in China according to Siewert's classification.
    Bai JG; Lv Y; Dang CX
    Jpn J Clin Oncol; 2006 Jun; 36(6):364-7. PubMed ID: 16766566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jan; 100(2):261-6. PubMed ID: 23180514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
    Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
    Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
    Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
    J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Surgical treatment of carcinomas of the oesophagogastric junction - results achieved in multicentre studies].
    Steinert R; Gastinger I; Ridwelski K; Ptok H; Wolff S; Meyer F; Otto R; Lippert H
    Zentralbl Chir; 2013 Aug; 138(4):403-9. PubMed ID: 23950077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
    Hagen JA; Peters JH; DeMeester TR
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
    Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
    Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenocarcinoma of the gastric cardia: treatment via a left thoracoabdominal approach.
    Lekakos LN; Triantafillopoulos JK; Milingos ND; Sfikakis PG
    Am Surg; 2002 Jul; 68(7):584-90. PubMed ID: 12132737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.
    Rüdiger Siewert J; Feith M; Werner M; Stein HJ
    Ann Surg; 2000 Sep; 232(3):353-61. PubMed ID: 10973385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
    Lee IS; Ahn JY; Yook JH; Kim BS
    World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment procedures for adenocarcinoma of the esophagogastric junction].
    Moesta KT; Hünerbein M; Schlag PM
    Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881
    [No Abstract]   [Full Text] [Related]  

  • 55. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
    Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
    Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
    Oh SE; Lee GH; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
    Eur J Surg Oncol; 2022 Feb; 48(2):370-376. PubMed ID: 34433514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.
    Siewert JR; Feith M; Stein HJ
    J Surg Oncol; 2005 Jun; 90(3):139-46; discussion 146. PubMed ID: 15895452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
    Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
    Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
    Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
    Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.